Guo, T., Yan, Y., Cao, W., Liu, Q., Zhu, H., Yang, L., . . . Xing, Y. (2018). Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis. Clinical rheumatology, 37(5), 1281-1293. https://doi.org/10.1007/s10067-018-4017-2
Chicago Style (17th ed.) CitationGuo, Tuan-Mao, Yong Yan, Wei-Ning Cao, Qiang Liu, Hai-Yun Zhu, Lan Yang, Mai-Cang Gao, and Yan-Li Xing. "Predictive Value of MicroRNA-132 and Its Target Gene NAG-1 in Evaluating Therapeutic Efficacy of Non-steroidal Anti-inflammatory Drugs Treatment in Patients with Ankylosing Spondylitis." Clinical Rheumatology 37, no. 5 (2018): 1281-1293. https://doi.org/10.1007/s10067-018-4017-2.
MLA (9th ed.) CitationGuo, Tuan-Mao, et al. "Predictive Value of MicroRNA-132 and Its Target Gene NAG-1 in Evaluating Therapeutic Efficacy of Non-steroidal Anti-inflammatory Drugs Treatment in Patients with Ankylosing Spondylitis." Clinical Rheumatology, vol. 37, no. 5, 2018, pp. 1281-1293, https://doi.org/10.1007/s10067-018-4017-2.